Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Parent

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Ecancermedicalscience|December 20, 2014
Hurdles and delays in access to anti-cancer drugs in EuropeF Ades, D Zardavas, C Senterre, et al.
American Journal of Respiratory and Critical Care Medicine|February 1, 1995
Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclinO Sitbon, F Brenot, A Denjean, et al.
Current Oncology (Toronto, Ont.)|September 9, 2020
Multidisciplinary management of locally advanced and metastatic cutaneous squamous cell carcinomaJ Claveau, J Archambault, D S Ernst, et al.
The European Respiratory Journal|August 13, 1999
Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot studyM Humbert, O Sanchez, M Fartoukh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2010
Durable responses to Erlotinib despite KRAS mutations in two patients with metastatic lung adenocarcinomaC Ferté, B Besse, E Dansin, et al.
American Journal of Hematology|May 1, 1995
Recombinant hirudin (HBW 023): biological data of ten patients with severe venous thrombo-embolismF Bridey, M Dreyfus, F Parent, et al.
Orthopaedics & Traumatology, Surgery & Research : OTSR|September 16, 2015
Minimally invasive posterior transforaminal lumbar interbody fusion: One-year postoperative morbidity, clinical and radiological results of a prospective multicenter study of 182 casesH Giorgi, R Prébet, M Delhaye, et al.
Thorax|August 9, 2005
Splenectomy and chronic thromboembolic pulmonary hypertensionX Jaïs, V Ioos, C Jardim, et al.
Presse Medicale (Paris, France : 1983)|July 15, 2003
[Pulmonary hypertension complicating systemic diseases other than connective tissue diseases]O Sanchez, G Garcia, A Hamid, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 1994
[Pulmonary arterial hypertension of chronic thromboembolic origin; therapeutic indications]R Azarian, F Brenot, O Sitbon, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Ecancermedicalscience|December 20, 2014
Hurdles and delays in access to anti-cancer drugs in EuropeF Ades, D Zardavas, C Senterre, et al.
American Journal of Respiratory and Critical Care Medicine|February 1, 1995
Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclinO Sitbon, F Brenot, A Denjean, et al.
Current Oncology (Toronto, Ont.)|September 9, 2020
Multidisciplinary management of locally advanced and metastatic cutaneous squamous cell carcinomaJ Claveau, J Archambault, D S Ernst, et al.
The European Respiratory Journal|August 13, 1999
Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot studyM Humbert, O Sanchez, M Fartoukh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2010
Durable responses to Erlotinib despite KRAS mutations in two patients with metastatic lung adenocarcinomaC Ferté, B Besse, E Dansin, et al.
American Journal of Hematology|May 1, 1995
Recombinant hirudin (HBW 023): biological data of ten patients with severe venous thrombo-embolismF Bridey, M Dreyfus, F Parent, et al.
Orthopaedics & Traumatology, Surgery & Research : OTSR|September 16, 2015
Minimally invasive posterior transforaminal lumbar interbody fusion: One-year postoperative morbidity, clinical and radiological results of a prospective multicenter study of 182 casesH Giorgi, R Prébet, M Delhaye, et al.
Thorax|August 9, 2005
Splenectomy and chronic thromboembolic pulmonary hypertensionX Jaïs, V Ioos, C Jardim, et al.
Presse Medicale (Paris, France : 1983)|July 15, 2003
[Pulmonary hypertension complicating systemic diseases other than connective tissue diseases]O Sanchez, G Garcia, A Hamid, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 1994
[Pulmonary arterial hypertension of chronic thromboembolic origin; therapeutic indications]R Azarian, F Brenot, O Sitbon, et al.
Pageof 9